MyMD Pharmaceuticals (MYMD) Competitors $0.36 -0.01 (-3.78%) As of 03/10/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsTrends MYMD vs. ALLR, MAAQ, TTNP, GRI, PPBT, CPHI, ATNF, SNPX, GENE, and SNOAShould you be buying MyMD Pharmaceuticals stock or one of its competitors? The main competitors of MyMD Pharmaceuticals include Allarity Therapeutics (ALLR), Mana Capital Acquisition (MAAQ), Titan Pharmaceuticals (TTNP), GRI Bio (GRI), Purple Biotech (PPBT), China Pharma (CPHI), 180 Life Sciences (ATNF), Synaptogenix (SNPX), Genetic Technologies (GENE), and Sonoma Pharmaceuticals (SNOA). These companies are all part of the "pharmaceutical products" industry. MyMD Pharmaceuticals vs. Allarity Therapeutics Mana Capital Acquisition Titan Pharmaceuticals GRI Bio Purple Biotech China Pharma 180 Life Sciences Synaptogenix Genetic Technologies Sonoma Pharmaceuticals Allarity Therapeutics (NASDAQ:ALLR) and MyMD Pharmaceuticals (NASDAQ:MYMD) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, community ranking, earnings, dividends, media sentiment, valuation, profitability and institutional ownership. Does the MarketBeat Community believe in ALLR or MYMD? Allarity Therapeutics received 1 more outperform votes than MyMD Pharmaceuticals when rated by MarketBeat users. CompanyUnderperformOutperformAllarity TherapeuticsOutperform Votes150.00% Underperform Votes150.00% MyMD PharmaceuticalsN/AN/A Does the media prefer ALLR or MYMD? In the previous week, Allarity Therapeutics had 4 more articles in the media than MyMD Pharmaceuticals. MarketBeat recorded 4 mentions for Allarity Therapeutics and 0 mentions for MyMD Pharmaceuticals. Allarity Therapeutics' average media sentiment score of 0.71 beat MyMD Pharmaceuticals' score of 0.00 indicating that Allarity Therapeutics is being referred to more favorably in the media. Company Overall Sentiment Allarity Therapeutics Positive MyMD Pharmaceuticals Neutral Which has more volatility & risk, ALLR or MYMD? Allarity Therapeutics has a beta of 0.26, suggesting that its stock price is 74% less volatile than the S&P 500. Comparatively, MyMD Pharmaceuticals has a beta of 2.15, suggesting that its stock price is 115% more volatile than the S&P 500. Is ALLR or MYMD more profitable? MyMD Pharmaceuticals' return on equity of -179.05% beat Allarity Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Allarity TherapeuticsN/A -369.67% -100.06% MyMD Pharmaceuticals N/A -179.05%-108.14% Do insiders and institutionals have more ownership in ALLR or MYMD? 11.5% of Allarity Therapeutics shares are owned by institutional investors. Comparatively, 9.6% of MyMD Pharmaceuticals shares are owned by institutional investors. 0.1% of Allarity Therapeutics shares are owned by company insiders. Comparatively, 2.1% of MyMD Pharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Which has preferable valuation and earnings, ALLR or MYMD? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAllarity TherapeuticsN/AN/A-$11.90MN/AN/AMyMD PharmaceuticalsN/AN/A-$4MN/AN/A SummaryAllarity Therapeutics beats MyMD Pharmaceuticals on 5 of the 9 factors compared between the two stocks. Remove Ads Get MyMD Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for MYMD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MYMD vs. The Competition Export to ExcelMetricMyMD PharmaceuticalsDiagnostic substances IndustryMedical SectorNASDAQ ExchangeMarket Cap$844,000.00$2.49B$5.64B$8.08BDividend YieldN/A0.70%4.89%4.04%P/E RatioN/A5.5423.7318.99Price / SalesN/A51.70381.75120.64Price / CashN/A15.7538.0534.64Price / Book0.053.086.904.26Net Income-$4M-$65.73M$3.18B$247.00M7 Day Performance-7.05%-4.21%6.75%-1.60%1 Month Performance-32.82%-11.80%0.16%-9.68%1 Year Performance-88.94%-23.47%13.62%1.96% MyMD Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MYMDMyMD PharmaceuticalsN/A$0.36-3.8%N/A-88.7%$844,000.00N/A0.006Gap DownALLRAllarity Therapeutics0.4743 of 5 stars$0.84-5.0%N/A-99.6%$3.69MN/A0.0010Upcoming EarningsBuyback AnnouncementHigh Trading VolumeMAAQMana Capital AcquisitionN/A$0.45-0.7%N/A-67.7%$3.65MN/A0.001Gap DownHigh Trading VolumeTTNPTitan Pharmaceuticals1.6022 of 5 stars$4.01-0.3%N/A-56.3%$3.62M$180,000.000.0010Short Interest ↓Gap DownGRIGRI Bio1.7506 of 5 stars$6.84-10.5%$195.50+2,758.2%-96.8%$3.59MN/A-0.591Gap DownPPBTPurple Biotech2.6543 of 5 stars$2.69-4.6%$33.00+1,126.8%N/A$3.58MN/A-0.3120Earnings ReportCPHIChina PharmaN/A$0.19-5.1%N/A-30.1%$3.56M$5.54M0.00250Gap UpATNF180 Life SciencesN/A$1.12-14.2%N/A-70.9%$3.55MN/A0.007Short Interest ↑Positive NewsGap DownSNPXSynaptogenix2.9382 of 5 stars$2.58-1.3%$14.00+443.7%-33.7%$3.49MN/A0.004Short Interest ↓Positive NewsGENEGenetic TechnologiesN/A$0.77flatN/AN/A$3.37M$7.66M0.0050High Trading VolumeSNOASonoma Pharmaceuticals1.0362 of 5 stars$2.09-1.7%N/A+2,407.1%$3.37M$13.97M-0.52180News CoverageGap Down Remove Ads Related Companies and Tools Related Companies ALLR Alternatives MAAQ Alternatives TTNP Alternatives GRI Alternatives PPBT Alternatives CPHI Alternatives ATNF Alternatives SNPX Alternatives GENE Alternatives SNOA Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MYMD) was last updated on 3/13/2025 by MarketBeat.com Staff From Our PartnersElon Musk Wants to Audit Fort Knox—What It Means for Your RetirementYou can take advantage of the coming tariff-fueled gold melt-up right inside your IRA or 401(k) – 100% TAX-FRE...Colonial Metals | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredAlert: DOGE goes liveElon will most likely be at the helm of it all. And just days from now, could bring about the biggest econo...Altimetry | SponsoredTrump doesn’t give a damnPorter Stansberry: “I met with Trump’s biggest backers… they’re scooping up these 10 stocks” I recently met...Porter & Company | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | SponsoredThe real reason gold is soaring (and likely to continue)Trump’s Policies Are Fueling a Gold Boom—Here’s Your Chance to Profit Donald Trump’s bold policies are driv...Golden Portfolio | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MyMD Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MyMD Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MYMD Stock Alerts